This finding suggests that the inability of Abx-treatment to drive leukemia progression in the Sca1-ETV6-RUNX1 model therefore, does not appear to be due to a failure to down-regulate Myd88 expression in precursor B-cells. This evidence concerns the gene ETV6 and leukemia.